Main > A1. CORP. INDEX. A-Am No. 2 > AbbVie Inc./P C2
This data is not available for free
AbbVie Inc./P C2's subsections
2012. 11.28. AbbVie Stock
2012. 12.07. AbbVie Stock
2013. 01.02. Launch
2013. 01.04. Dividend
2013. 05.20. Diabetic Nephro.
2013. 06.17. Onco.>CLL & NHL *
2013. 09.23. Inflammatory>RA&SLE
2013. 09.24. CF>Galapagos
2014. 02.05. SG>US$320M Inv.>Mfg.
2014. 04.12. Hepato.>HCV+Cirrhosis
2014. 05.30. Onco.>Glioblastoma
2014. 06.03. IE>Sligo>Mfg. Facility
2014. 09.03. Calico
2014. 09.03. Onco.>Infinity Pharma.
2014. 09.11. Derma.>HS
2014. 09.25. GI.>Crohns>Pediatrics
2014. 11.21. SG>Acq. Mfg. Facility
2015. 01.12. Neuro.>PD
2015. 03.04. Acq. Pharmacyclics
2015. 05.26. Acq. Pharmacyclics
2015. 07.10. Onco.>WM
2015. 08.19. United Therapeutics
2015. 09.28. Hepato.>HCV
2015. 11.30. Onco.>MM
2016. 01.06. Derma.>HD
2016. 04.11. Onco.>CLL>V USA>OK
2016. 04.20. Onco.>Uni. Chicago
2016. 04.21. Argenx
2016. 04.21. CytomX
2016. 04.28. Acq. StemCentrx
2016. 05.27. Neuro.>MS
2016. 05.31. Onco.>CLL>I
2016. 06.30. Ophthalmo.>Uveitis
2016. 07.25. Hepato.>HCV
2017. 01.19. Onco.>NHL>MZL
2017. 07.28. Hepato.>HCV (*)
2017. 10.10. Turnstone Biologics
2017. 10.24. Alector
2018. 07.24. Gyne.>Endometriosis
2018. 10.18. Morphic Therapeutic
2018. 11.01. Onco.>CLL>V EU>OK
2019. 01.28. Onco.>CLL/SLL
2019. 02.20. Voyager Therapeutics
2019. 03.26. Psoriasis>JP>Approval
2019. 04.18. Psoriasis>CA>Approval
2019. 04.23. Psoriasis>USA>Approval
2019. 05.15. Onco.>CLL
2019. 06.25. Acq. Allergan
2019. 07.15. Onco.>Acq. MavuPharma
2019. 08.02. Hepato.>HCV (*)
2019. 08.16. Rheuma.>RA USA>OK
2019. 09.26. Hepato.>HCV (*)
2019. 11.21. Harpoon Therapeutics
2019. 12.18. Rheuma.>RA EU>OK
2020. 05.29. Gyne.>Uterine Fibroids
2020. 06.10. Onco.>Genmab
2020. 09.04. Onco.>I-Mab
2021. 01.25. PsA & AS>Upadacitinib
2021. 02.10. Caribou Biosciences
2021. 02.24. GI.>UC>5>USA>OK
2021. 06.24. Onco.>MM>Acq. TeneoOne
2021. 07.27. Calico
2021. 09.13. Regenxbio
2021. 09.28. Migraine
2021. 10.29. Ophthalmo.>Presbyopia
2021. 12.14. Rheuma.>PsA>USA>OK
2022. 02.08. FDA Approves
2022. 03.01. Acq. Syndesi Therapeut
2022. 03.11. Gedeon Richter
2022. 03.16. Gastro.>UC>USA>OK
2022. 04.29. Rheuma.>AS>USA>OK
2022. 05.16. AutoImmune>Cugene
2022. 06.17. Gastro.>CD>USA>OK
2022. 07.29. Rheuma.>nr-axSpA>EU>OK
2022. 10.21. Rheuma.>nr-axSpA>US>OK
2022. 11.23. Gastro.>CD>EU>OK
2023. 04.17. Gastro.>CD>EU>OK
2023. 04.17. Migraine>FDA Approves
2023. 05.19. Onco.>DLBCL>USA>OK
2023. 10.05. Acq. Mitokinin
2023. 11.30. Acq. ImmunoGen
2024. 01.09. Neuro.>AD>EU Launch
2024. 03.22. Onco.>Ovarian C.>Full>
2024. 03.25. Acq. Landos Biopharma
Pharmacyclics./P C2
Web-Site
AbbVie Inc./P C2's products
This section has no products